Federal grants to The General Hospital Corporation
The General Hospital Corporation in Boston, Massachusetts received $3.0 billion in federal grants from fiscal 2021 to 2025, across 2,205 awards. Its largest program was Aging Research, with $427 million. In fiscal 2025 it was awarded $649 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.0 billion
- Awards2,205
- Awarded in FY 2025$649 million
- Largest award$46.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 990 | $541 million |
| FY 2022 | 1,039 | $561 million |
| FY 2023 | 1,082 | $635 million |
| FY 2024 | 1,061 | $632 million |
| FY 2025 | 1,031 | $649 million |
Programs that fund The General Hospital Corporation
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 277 | $427 million |
| Allergy and Infectious Diseases Research | 203 | $310 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 203 | $288 million |
| Cardiovascular Diseases Research | 191 | $277 million |
| Mental Health Research Grants | 162 | $199 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 152 | $186 million |
| Trans-NIH Research Support | 59 | $145 million |
| Military Medical Research and Development | 92 | $118 million |
| Drug Use and Addiction Research Programs | 69 | $116 million |
| Cancer Treatment Research | 62 | $107 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 2,087 | $2.9 billion |
| Department of Defense | 95 | $139 million |
| National Aeronautics and Space Administration | 10 | $4.7 million |
| National Science Foundation | 8 | $4.0 million |
| Department of Justice | 2 | $1.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Discovery: determinants of incident stroke cognitive outcomes and vascular effects on recovery | Aging Research | November 18, 2020 | $46.5 million |
| Intermediate-size expanded access trial of autologous hybrid treg/TH2 cell therapy (RAPA-501) of amyotrophic lateral sclerosis - als is a lethal neurodegenerative disease accelerated by neuroinflammation. Current fda-approved therapies have modest benefits and do not address inflammation. To address | Trans-NIH Research Support | September 22, 2023 | $33.0 million |
| An intermediate-size expanded access protocol for amyotrophic lateral sclerosis with pridopidine - the sigma 1 receptor (S1R) has emerged as an attractive therapeutic target in als. Mutations in the S1R are causative of als and the degree of loss of function in S1R protein determines age of onset. S | Trans-NIH Research Support | September 22, 2023 | $27.9 million |
| Massachusetts alzheimer's disease research center | Aging Research | November 3, 2020 | $19.9 million |
| An expanded access protocol of intravenous trehalose injection 90 mg/ml treatment of patients with amyotrophic lateral sclerosis - amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative. There are two fda-approved medications to slow als progression, riluzole and edaravone; t | Trans-NIH Research Support | September 28, 2022 | $18.1 million |
| 2022 military medical photonics program at wellman center for photomedicine | Air Force Defense Research Sciences Program | September 15, 2023 | $17.6 million |
| R&d, science and engineering, in the area of medical sciences | Military Medical Research and Development | February 4, 2021 | $16.4 million |
| Center for innovative neurotech advancement - cinta - project abstract - overall we propose to create the center for innovative neurotech advancement (CINTA), a new center for rapid transformation of emerging technologies into commercially viable, clinically focused solutions for disorders of the NE | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 15, 2023 | $16.2 million |
| Targeting inflammation and alloimmunity in lung transplant recipients with clazakizumab - project summary/abstract the 5-YEAR survival after lung transplantation is a dismal 53% and chronic lung allograft dysfunction (CLAD) has emerged as the primary obstacle to better long-term outcomes. Clearly, c | Allergy and Infectious Diseases Research | September 14, 2021 | $15.5 million |
| Clinical coordinating center network of excellence in neuroscience clinical trial | Extramural Research Programs in the Neurosciences and Neurological Disorders | August 11, 2021 | $14.9 million |
Questions people ask
How much federal grant money does The General Hospital Corporation get?
$3.0 billion in 2,205 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The General Hospital Corporation the most?
The Department of Health and Human Services, with $2.9 billion in 2,087 awards. The Department of Defense and the National Aeronautics and Space Administration follow.
What is The General Hospital Corporation's largest federal grant?
$46.5 million under Aging Research, with its first action in the period on November 18, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The General Hospital Corporation?
Its largest are Aging Research, Allergy and Infectious Diseases Research and Extramural Research Programs in the Neurosciences and Neurological Disorders.
Other grant recipients in Boston
- The Commonwealth of Massachusetts
- Massachusetts Department of Transportation
- Massachusetts Bay Transportation Authority
- Department of Transitional Assistan
- Massachusetts Department of Public Health
- Brigham & Womens Hospital Inc
- Executive Office of Housing and Livable Communities
- Massachusetts Department of Early Education & Care
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts